Therapy Areas: Infectious Diseases
Therapix Biosciences Drug Candidate THX-160 Demonstrates Efficacy in Treatment of Pain
20 July 2018 - - Tel Aviv, Israel-based cannabinoid-based treatments developer Therapix Biosciences Ltd. (NASDAQ: TRPX) has released positive results in its pre-clinical studies evaluating THX-160, a ...
Clinigen buys rights to Proleukin from Novartis
18 July 2018 - Clinigen Group plc (AIM: CLIN) has acquired the global rights to Proleukin (aldesleukin, recombinant interleukin-2) outside the United States from Swiss-based Novartis International AG ...
Mermel Joins Citius Scientific Advisory Board
18 July 2018 - - Lawrence Mermel has accepted a position on the Cranford, New Jersey-based specialty pharmaceutical company Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) scientific advisory board, the c...
First Drug with Indication for Treatment of Smallpox Approved by US FDA
18 July 2018 - - Silver Spring, Maryland-based public health protection provider US Food and Drug Administration has approved Tpoxx (tecovirimat), the first drug with an indication for treatment of sm...
US FDA Clears Roche PCT Assay for Use in Antibiotic Treatment Decisions
18 July 2018 - - Basel, Switzerland-based biotech company Roche (SIX: RO) (OTCQX: RHHBY) has received clearance from the US Food and Drug Administration for the expanded use of its Elecsys B·R&...
Review Timeline for Invokana (canagliflozin) sNDA Extended by Three Months
18 July 2018 - - The US Food and Drug Administration has extended the review timeline for Janssen Pharmaceutical Companies' supplemental New Drug Application (sNDA) for Invokana (canagliflozin), ...